To better understand the clinical applicability of cfDNA assays, we developed a hybridization capture-based panel targeting the most common translocation partners in two pediatric cancers, specifically EWSR1 for Ewing sarcoma and FOXO1 in ARMS5. This evidence concerns the gene FOXO1 and Ewing sarcoma.